The DOI matches its Crossref record.
From Aging to Alzheimer's Disease: Unveiling “The Switch” with the Senescence-Accelerated Mouse Model (SAMP8)
Abstract
Current mouse models of Alzheimer's disease (AD) are restricted to the expression of AD-related pathology associated with specific mutations present in early-onset familial AD and thus represent < 5% of AD cases. To date there are no mouse lines that model late-onset/age-related AD, the feature which accounts for the vast majority of cases. As such, based on current mutation-associated models, the chronology of events that lead to the disease in the aged population is difficult to establish. However, published data show that senescence-accelerated mouse (SAMP8), as a model of aging, display many features that are known to occur early in the pathogenesis of AD such as increased oxidative stress, amyloid-beta alterations, and tau phosphorylation. Therefore, SAMP8 mice may be an excellent model for studying the earliest neurodegenerative changes associated with AD and provide a more encompassing picture of human disease, a syndrome triggered by a combination of age-related events. Here, the neurochemical, neuropathological, and behavioral alterations, characterized in SAMP8 mice are critically reviewed and discussed in relation to the potential use of this mouse model in the study of AD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oxidative stress and β-amyloid protein in Alzheimer’s disease
Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279
“Oxidative stress is an early feature of AD pathology (Aluise et al. 2010; Pallas et al. 2008; Singh et al. 2010).”
BackgroundDietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8
Porquet, D., Casadesús, G., Bayod, S., Vicente, A., Canudas, A. M., Vilaplana, J., Pelegrí, C., Sanfeliu, C., Camins, A., Pallàs, M., et al. (2013) · AGE · doi:10.1007/s11357-012-9489-4 · Cited by 262
Self-citationPhysical Exercise Protects Against Alzheimer's Disease in 3xTg-AD Mice
García-Mesa, Y., López-Ramos, J. C., Giménez-Llort, L., Revilla, S., Guerra, R., Gruart, A., LaFerla, F. M., Cristòfol, R., Delgado-García, J. M., & Sanfeliu, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101635 · Cited by 253
Melatonin and sirtuins: A “not-so unexpected” relationship
Mayo, J. C., Sainz, R. M., González Menéndez, P., Cepas, V., Tan, D., & Reiter, R. J. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12391 · Cited by 175
Liu, B., Liu, J., & Shi, J.-S. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200063 · Cited by 156
Advance of sporadic Alzheimer's disease animal models
Zhang, L., Chen, C., Mak, M. S., Lu, J., Wu, Z., Chen, Q., Han, Y., Li, Y., & Pi, R. (2020) · Medicinal Research Reviews · doi:10.1002/med.21624 · Cited by 116
Banik, A., Brown, R. E., Bamburg, J., Lahiri, D. K., Khurana, D., Friedland, R. P., Chen, W., Ding, Y., Mudher, A., Padjen, A. L., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150136 · Cited by 102
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
“Pallas et al. (2008) provided one pos- sible solution to the limitation of FAD-reproducing mouse models compared to sporadic/late-onset AD, proposing a new non-transgenic senescence-accelerated prone mouse strain 8 (SAMP8).”
Whittemore, K., Derevyanko, A., Martinez, P., Serrano, R., Pumarola, M., Bosch, F., & Blasco, M. A. (2019) · Aging · doi:10.18632/aging.101982 · Cited by 69
“Future studies warrant analysis of telomere length in other models of Alzheimer’s disease, such as including the APP/PS1 mouse model, expressing mutated amyloid precursor protein (APP) and mutated presenilin (PS1) [95], the SAMP8 (Senescence Accelerated Mouse-Prone 8) mouse model [96], which exhibits features of accel…”
BackgroundPorquet, D., Andrés-Benito, P., Griñán-Ferré, C., Camins, A., Ferrer, I., Canudas, A. M., Del Valle, J., & Pallàs, M. (2015) · AGE · doi:10.1007/s11357-015-9747-3 · Cited by 53
Self-citationWalia, V., Chaudhary, S. K., & Kumar Sethiya, N. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2020.104939 · Cited by 51
Mechanism of anti-dementia effects of mangiferin in a senescence accelerated mouse (SAMP8) model
Du, Z., Fanshi, F., Lai, Y.-H., Chen, J.-R., Hao, E., Deng, J., & Hsiao, C.-D. (2019) · Bioscience Reports · doi:10.1042/bsr20190488 · Cited by 30
García‐Matas, S., Paul, R. K., Molina‐Martínez, P., Palacios, H., Gutierrez, V. M., Corpas, R., Pallas, M., Cristòfol, R., de Cabo, R., & Sanfeliu, C. (2015) · Aging Cell · doi:10.1111/acel.12259 · Cited by 22
Sumsuzzman, D. M., Khan, Z. A., Choi, J., & Hong, Y. (2021) · Aging · doi:10.18632/aging.202894 · Cited by 19
Metadata
- Authors
- Pallas, M., Camins, A., Smith, M. A., Perry, G., Lee, H.-G., & Casadesus, G.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2008-12-17
- Volume
- 15
- Issue
- 4
- Pages
- 615-624
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W48640801
- Cited by
- 198
- References
- 0
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.